Updated 20:03 GMT, 5 Nov 2026 SPX 7,400.37 -3.75% NDX 26,906.42 -5.38% VIX 24.13 +45.27% GOLD 4,127.00 +1.33% CL 90.56 +2.77% BTC 76,158.55 -5.28%
NAS100 26,906 −5.38% S&P 7,400 −3.75% GOLD $4,127 +1.33% BTC $76,159 −5.28% VIX 24.13 +45.27% latest tape · as of 20:03 UTC
The Screen · Consumer Cyclical · Residential Construction

Taylor Morrison Home Corporation logoTaylor Morrison Home Corporation

TMHC · the NYSE · USD · Market cap $6.8B · 2,800 employees

Taylor Morrison Home Corporation, together with its subsidiaries, operates as a homebuilder and land developer in the United States.

Not yet scored
72.45 USD

Price as of 11 Sep 2026Daily close, not a live quoteLast reviewed 55 days ago

Screened 2026-09-11 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price72.45 USD at the 11 Sep 2026 close
  • Fair valueUnder review: its inputs are 55 days old.
  • Our regime readMarkup, as of 1 Nov 2026
  • Ethical screenNot yet scored
  • Last reviewed11 Sep 2026 (55 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-09-11).

Current read
Markup ?
Screened · screened 2026-09-11
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical screen not yet scored
Price72.45 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-08-14Read Markup72.45+0.0% to today ✓Markdown gives way to Markup
2026-07-02Read Markdown71.90+0.8% to today First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Taylor Morrison Home Corporation holds its Markup at $72.45. Consolidating, no directional conviction, held for 6 days.

As held on the ledger · 2026-09-11
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 6 days
Price at the screen$72.45
Valuation10.80 trailing · 11.53 forward price to earnings
Values screenNot scored · score 70.0
Beta1.44
The Workings

Five Screens, Shown in Full

This security has not been fully scored against the values screen yet.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 24.02% Below 33% Interest-bearing debt is just 24.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 11.10% Below 49% Money owed to the company is 11.1% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

The Read, in Plain English

Taylor Morrison Home clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.

2026-10-25

Taylor Morrison Home clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

2026-09-24 Clears

Taylor Morrison Home clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.

Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Its inputs are 55 days old. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

The Street's Range
49.00Street low 72.50Street average 73.00Street high 72.45Price

Third-party analyst targets: 4 covering, consensus Hold. The average target sits +0% from the screen price.

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-09-11 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Homebuilder Sells at a Premium to Value

Picture a family signing for their first home in Phoenix just as mortgage rates climb and buyer traffic slows. Taylor Morrison builds those houses across the Sun Belt, yet the numbers show revenue dropping 27 percent and a forward multiple of 11.3 times that flatters peak-cycle earnings. We pass because the shares sit 10 percent above our fair value and the business carries no clear moat in a market that has already turned.

The low multiple looks tempting until you remember this is residential construction. Profit margins sit at 9 percent and return on equity at 11 percent, both typical for the sector near the top of a housing cycle. When volumes fall further the same earnings can compress quickly, turning an apparently cheap multiple into a value trap rather than a bargain.

Ethical checks clear and four analysts sit on hold with a 72 dollar median target, but that consensus simply mirrors the current price and offers no margin of safety. Currency or regulatory shocks are absent here; the real exposure is to interest rates and consumer confidence that remain outside the company's control. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E11.5xreasonably valued
Trailing P/E10.8xreasonably valued
EPS, trailing6.71
EPS, forward6.29
Revenue growth-26.8%revenue is shrinking
Profit margin8.8%thin but positive margins
Return on equity11.1%a modest return on shareholder capital
FCF yield7.56%
Debt to equity0.39minimal debt: a conservative balance sheet
Current ratio9.26comfortably covers its short-term bills
Beta1.44moves a little more than the market
Short interest, float0.04%
52-week range54.15 - 72.50
Market cap$6.8B
Employees2,800

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

TMHC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-04 Markup $72.45 +0.0% Entry 8

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.

2026-10-23 Markup $72.45 +0.0% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.

2026-10-02 Markup $72.45 +0.0% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.

2026-09-14 Markup $72.45 +0.0% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.

2026-08-14 Markup · changed $72.45 +0.8% Entry 4

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.

2026-07-18 Markdown $71.90 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.

2026-07-03 Markdown $71.90 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markdown $71.90 Entry 1

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on TMHC

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in TMHC's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $59.30 +20.7% · $1,207 +20.7%
2 months $59.41 +20.5% · $1,205 +20.5%
3 months $58.86 +21.6% · $1,216 +21.6%
6 months $63.03 +13.6% · $1,136 +13.6%
1 year $59.70 +19.9% · $1,199 +19.9%
2 years $56.11 +27.6% · $1,276 +27.6%
3 years $46.70 +53.3% · $1,533 +53.3%
5 years $27.87 +156.9% · $2,569 +156.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever TMHC does next, these words stay.

Taylor Morrison Home Corporation · TMHC · Markup · $72.45
Recorded 2026-09-11 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.